µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics.
Denys OliinykAndreas WillFelix R SchneidmadelMaximilian BöhmeJenny RinkeAndreas HochhausThomas ErnstNina HahnChristian GeisMarkus LubeckOliver RaetherSean J HumphreyFlorian MeierPublished in: Molecular systems biology (2024)
Mass spectrometry has revolutionized cell signaling research by vastly simplifying the analysis of many thousands of phosphorylation sites in the human proteome. Defining the cellular response to perturbations is crucial for further illuminating the functionality of the phosphoproteome. Here we describe µPhos ('microPhos'), an accessible phosphoproteomics platform that permits phosphopeptide enrichment from 96-well cell culture and small tissue amounts in <8 h total processing time. By greatly minimizing transfer steps and liquid volumes, we demonstrate increased sensitivity, >90% selectivity, and excellent quantitative reproducibility. Employing highly sensitive trapped ion mobility mass spectrometry, we quantify ~17,000 Class I phosphosites in a human cancer cell line using 20 µg starting material, and confidently localize ~6200 phosphosites from 1 µg. This depth covers key signaling pathways, rendering sample-limited applications and perturbation experiments with hundreds of samples viable. We employ µPhos to study drug- and time-dependent response signatures in a leukemia cell line, and by quantifying 30,000 Class I phosphosites in the mouse brain we reveal distinct spatial kinase activities in subregions of the hippocampal formation.
Keyphrases
- mass spectrometry
- endothelial cells
- high resolution
- liquid chromatography
- single cell
- induced pluripotent stem cells
- pluripotent stem cells
- signaling pathway
- acute myeloid leukemia
- high throughput
- squamous cell carcinoma
- gas chromatography
- protein kinase
- bone marrow
- papillary thyroid
- high performance liquid chromatography
- emergency department
- squamous cell
- stem cells
- oxidative stress
- gene expression
- cell proliferation
- young adults
- childhood cancer
- brain injury
- dna methylation
- tandem mass spectrometry
- pi k akt
- adverse drug
- living cells
- lymph node metastasis